Therapeutic targeting of cathepsin C: from pathophysiology to treatment

Thrusday, February 10, 2022 – 11am – Salle 42A and on TEAMS

Dr. Brice Korkmaz, Université de Tours, France

Related publications: 

• Cathepsin C inhibition as a potential treatment strategy in cancer. Korkmaz B, Lamort AS, Domain R, Beauvillain C, Gieldon A, Yildirim AÖ, Stathopoulos GT, Rhimi M, Jenne DE, Kettritz R. Biochem Pharmacol. 2021 Dec;194:114803.
• Lung Protection by Cathepsin C Inhibition: A New Hope for COVID-19 and ARDS? Korkmaz B, Lesner A, Marchand-Adam S, Moss C, Jenne DE. J Med Chem. 2020 Nov 25;63(22):13258-13265.
• Therapeutic targeting of cathepsin C: from pathophysiology to treatment. Korkmaz B, Caughey GH, Chapple I, Gauthier F, Hirschfeld J, Jenne DE, Kettritz R, Lalmanach G, Lamort AS, Lauritzen C, Łȩgowska M, Lesner A, Marchand-Adam S, McKaig SJ, Moss C, Pedersen J, Roberts H, Schreiber A, Seren S, Thakker NS. Pharmacol Ther. 2018 Oct;190:202-236

Info: rita.vanbever@uclouvain.be